DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Valiant Laboratories Limited — Board Meeting Intimation

NSE 2 hrs ago·5 Aug 2026, 9:34 am

Valiant Laboratories

Valiant Laboratories Limited has announced that its board will meet on August 10, 2026, to review and approve the company's audited financial results for the quarter ended June 2026. This is a standard corporate procedure where the board evaluates the company's performance before the data is officially released to the public.

For investors, this announcement is a key milestone as it provides the first official confirmation of the company's financial health for the period. The results will reveal how well the business is performing, including its revenue, expenses, and profitability, which are crucial factors in assessing the stock's current value.

Investors should watch for the official release of these results. The market will react to the numbers, and any guidance provided by the management regarding future performance will be critical in determining the stock's next direction.